Your browser doesn't support javascript.
Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11].
Turco, Fabio; Armstrong, Andrew; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob G; Bulbul, Muhammad; Caffo, Orazio; Chi, Kim N; Clarke, Caroline; Clarke, Noel; Davis, Ian D; de Bono, Johann; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; Evans, Christopher P; Fanti, Stefano; Feng, Felix Y; Fizazi, Karim; Frydenberg, Mark; George, Dan; Gleave, Martin; Halabi, Susan; Heinrich, Daniel; Higano, Celestia; Hofman, Michael S; Hussain, Maha; James, Nicholas; Jones, Rob; Kanesvaran, Ravindran; Khauli, Raja B; Klotz, Laurence; Leibowitz, Raya; Logothetis, Christopher; Maluf, Fernando; Millman, Robin; Morgans, Alicia K; Morris, Michael J; Mottet, Nicolas; Mrabti, Hind; Murphy, Declan G; Murthy, Vedang; Oh, William K; Ekeke, Onyeanunam Ngozi; Ost, Piet.
  • Turco F; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy. Electronic address: turcofabio9@gmail.com.
  • Armstrong A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA.
  • Attard G; University College London Cancer Institute, London, UK.
  • Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Beltran H; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden.
  • Bossi A; Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France.
  • Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
  • Bristow RG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust and CRUK Manchester Institute and Cancer Centre, Manchester, UK.
  • Bulbul M; Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
  • Caffo O; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Chi KN; BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Clarke C; Research Department of Primary Care & Population Health, Royal Free Campus, University College London, Rowland Hill St, London, UK.
  • Clarke N; The Christie and Salford Royal Hospitals, Manchester, UK.
  • Davis ID; Monash University and Eastern Health, Victoria, Australia.
  • de Bono J; The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK.
  • Duran I; Department of Medical Oncology. Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
  • Eeles R; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
  • Efstathiou E; Houston Methodist Cancer Center, Houston, TX, USA.
  • Efstathiou J; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Evans CP; University of California Davis School of Medicine, Sacramento, CA, USA.
  • Fanti S; Policlinico S. Orsola, Università di Bologna, Bologna, Italy.
  • Feng FY; University of California, San Francisco, San Francisco, CA, USA.
  • Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Frydenberg M; Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Department of Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia.
  • George D; Departments of Medicine and Surgery, Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway.
  • Higano C; University of British Columbia, Vancouver, British Columbia, Canada.
  • Hofman MS; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • James N; The Institute of Cancer Research, London, UK.
  • Jones R; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore.
  • Khauli RB; Department of Urology and the Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon.
  • Klotz L; Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Leibowitz R; Oncology institute, Shamir Medical Center, Zerifin, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Logothetis C; Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, Athens, Greece; David H. Koch Centre, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer
  • Maluf F; Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brasil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Millman R; Patient Advocate, UK.
  • Morgans AK; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Morris MJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mottet N; University Hospital Nord St Etienne, St Etienne, France.
  • Mrabti H; National Institute of Oncology, University Hospital, Rabat, Morocco.
  • Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Murthy V; Tata Memorial Centre, Mumbai, India.
  • Oh WK; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA.
  • Ekeke ON; Department of Surgery, University of Port Harcourt Teaching Hospital, Alakahia, Port Harcourt, Nigeria.
  • Ost P; Department of Radiation Oncology, Iridium Netwerk, Wilrijk (Antwerp), Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Eur Urol ; 82(1): e18-e19, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-2068987
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Eur Urol Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Eur Urol Year: 2022 Document Type: Article